Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9337217 | Clinical Radiology | 2005 | 5 Pages |
Abstract
None of the group receiving warfarin experienced clinically important bleeding complications. Our results suggest that the frequency and severity of bleeding complications were no worse in the warfarin group than in the control group and that discontinuing anticoagulation medication before prostate biopsy may be unnecessary.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
C.U. Ihezue, J. Smart, K.C. Dewbury, R. Mehta, L. Burgess,